FKBP

From WikiMD's WELLNESSPEDIA

File:Fkbp-cartoon-1fkj.png
Cartoon representation of FKBP protein structure

FKBP, or FK506-binding protein, is a family of proteins that have a high affinity for the immunosuppressive drug Tacrolimus (also known as FK506). These proteins are characterized by their ability to bind to immunophilins and are involved in various cellular processes, including protein folding and trafficking.

Structure[edit]

FKBP proteins are known for their peptidyl-prolyl isomerase (PPIase) activity, which catalyzes the cis-trans isomerization of proline residues in polypeptide chains. This activity is crucial for proper protein folding and function. The structure of FKBP proteins typically includes a conserved FKBP domain, which is responsible for their binding activity.

Function[edit]

The primary function of FKBP proteins is to assist in protein folding and to act as molecular chaperones. They are also involved in the regulation of cell signaling pathways. FKBP12, one of the most studied members of this family, binds to the calcium release channel ryanodine receptor and modulates its activity.

Clinical Significance[edit]

FKBP proteins are significant in the field of immunology due to their role in the mechanism of action of immunosuppressive drugs like Tacrolimus. By binding to FKBP, Tacrolimus inhibits the activity of calcineurin, a phosphatase involved in T-cell activation, thereby suppressing the immune response. This makes FKBP proteins a target for therapeutic interventions in organ transplantation and autoimmune diseases.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.